On August 30, 2013, Michael Fonstein, Ph.D. stepped down from his position as President of Cleveland BioLabs, Inc., effective as of August 31, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | 0.00% | 0.00% | -99.98% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+40.68% | 55.66B | |
-8.59% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+9.30% | 26.29B | |
-15.61% | 20.25B | |
+30.63% | 12.76B | |
+26.46% | 12.18B | |
-1.81% | 12.12B |
- Stock Market
- Equities
- STAB Stock
- STAB Stock
- News Statera Biopharma, Inc.
- Michael Fonstein Steps Down as President of Cleveland BioLabs